Somerset Pharmaceuticals in Tampa, FL offers EMSAM, the first and only selegiline patch indicated for major depressive disorder in adults. Their transdermal system has been shown to be more effective than placebo on the Hamilton Depression Rating Scale and has a longer time to relapse compared to placebo.
EMSAM contains selegiline, a monoamine oxidase inhibitor antidepressant, designed to deliver medication over a 24-hour period when applied to intact skin. The company emphasizes the importance of closely monitoring patients for suicidal thoughts and behaviors, and provides a Savings Card Program for eligible, commercially insured patients to save up to $600 on their medication.
Generated from the website